EpiUnic

You may also be interested in

AUP-16 (AUP1602-C)

AUP-16 multi-targeting therapy for chronic wounds (Diabetic Foot Ulcers...) shows 50% improvement vs placebo in Phase-2 RCT

Phase II completed

Bimiralisib, topical [PQR309] (panPI3K/mTOR)

Non-melanoma skin cancers and rare genetic skin manifestations.

Discovery

TOP-N53, TOP-V122 and TOP-M119

TOPADUR has discovered and developed new dual-acting drugs that target the cGMP-Enzyme Regulation System to stimulate microcirculation, enable tissue regeneration, and avoid local oxygen deficiency. Based on our key invention we have developed an attractive portfolio of drug candidates to treat aging-related diseases as chronic wounds, glaucoma, colorectal cancer, hair loss and skin aging.